1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)
  4. Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/217318
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVega González, Silvia-
dc.contributor.authorToledo Jara, Michele-
dc.contributor.authorAlvarez Esteban, Rafael-
dc.contributor.authorHueso Val, Miguel-
dc.contributor.authorRodriguez Urquia, Ronny Isaac-
dc.contributor.authorQuero Ramos, Maria-
dc.contributor.authorColoma, Ana-
dc.contributor.authorManonelles, Anna-
dc.contributor.authorCouceiro, Carlos-
dc.contributor.authorRama, Inés-
dc.contributor.authorCruzado, Josep Ma.-
dc.contributor.authorSandoval, Diego-
dc.date.accessioned2025-01-08T12:28:57Z-
dc.date.available2025-01-08T12:28:57Z-
dc.date.issued2024-05-01-
dc.identifier.issn1460-2385-
dc.identifier.urihttps://hdl.handle.net/2445/217318-
dc.descriptionComunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024-
dc.description.abstractLiving donor transplantation is the best optimal choice for the vast majority of patients with terminal renal insufficiency. However, it is limited by the AB0/ HLA incompatibility between donor and receptor. The resolution of this inconvenient relies on desensitization of isoagglutinins (anti-AB0 immunoglobulins depletion); thus transplantation could be performed safely.-
dc.format.extent2 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherOxford University Press (OUP)-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1093/ndt/gfae069.758-
dc.relation.ispartofNephrology Dialysis Transplantation, 2024, vol. 39, sup. 1, p. i1244-i1245-
dc.relation.urihttps://doi.org/10.1093/ndt/gfae069.758-
dc.rights(c) Vega González, Silvia et al., 2024-
dc.sourceComunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationTrasplantament renal-
dc.subject.classificationRebuig (Biologia)-
dc.subject.otherKidney transplantation-
dc.subject.otherGraft rejection-
dc.titleDesensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications-
dc.typeinfo:eu-repo/semantics/conferenceObject-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.date.updated2024-12-13T09:48:11Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
gfae069-0758-2917.pdf251.53 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.